PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi Syndrome

Por um escritor misterioso

Descrição

A typical six-month-old girl with Rubinstein–Taybi syndrome was presented with typical facial changes including downward-sloping palpebral fissures, prominent forehead, hypertelorism, limited mouth opening, large beaked nose, and high arched palate. Rubinstein–Taybi syndrome (RTS) was first described by Michail et al[1] and subsequently by Rubinstein and Taybi[2]. We present a typical six-month-old girl with RTS. Her mother had ovarian cancer and polyhydramnios during the pregnancy. Parents are closely related. There were frequent respiratory infections resulting in two hospital admissions. Physical examination revealed typical facial changes including downward-sloping palpebral fissures, prominent forehead, hypertelorism, limited mouth opening, large beaked nose, and high arched palate (Fig. 1). A history of increased tearing was compatible with nasolacrimal duct obstruction. Other features include general hypotonia with delayed developmental milestones, short and broad thumbs and toes (Fig. 1). Chest x-ray showed cardiomegaly (Fig. 2). She had normal karyotype.
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
PDF) Patent ductus arteriosus: The physiology of transition
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
PDF] Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Transcatheter closure of patent ductus arteriosus in a tiniest baby – 510 grams - ScienceDirect
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
PDF] Patent Ductus Arteriosus Closure in Prematurities Weighing Less than 1 Kg by Subaxillary Mini-thoracotomy
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Clinical outcomes of different patent ductus arteriosus treatment in preterm infants born between 28 and 32 weeks in Taiwan - ScienceDirect
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
PDF) Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi Syndrome
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
pda 27.7.23.pptx
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Frontiers Molecular and Mechanical Mechanisms Regulating Ductus Arteriosus Closure in Preterm Infants
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Transcatheter closure of patent ductus arteriosus in a tiniest baby – 510 grams - ScienceDirect
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Pediatric Cardiothoracic Surgery - Patent Ductus Arteriosus
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Transcatheter closure of patent ductus arteriosus in a tiniest baby – 510 grams - ScienceDirect
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
Frontiers Molecular and Mechanical Mechanisms Regulating Ductus Arteriosus Closure in Preterm Infants
PDF] Patent Ductus Arteriousus Device Closure in an Infant with Rubinstein–Taybi  Syndrome
PDF] Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications
de por adulto (o preço varia de acordo com o tamanho do grupo)